In addition, CD248 upregulation is associated with poor prognosis of renal cell carcinoma (Xu et al., 2021), urothelial carcinoma (Li et al., 2021), hepatocellular carcinoma (Yang et al., 2020), colorectal cancer (Pietrzyk and Wdowiak, 2020), and so on. The gene discussed is CD248; the disease is hepatocellular carcinoma.